ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
Longer reproductive window could up risk for Alzheimer’s disease
Jul 12, 2021
The authors suggest that longer exposure to endogenous estrogen may be associated with increased levels of Alzheimer’s disease biomarkers.
Ad26.COV2.S, mRNA boosters immunogenic after Ad26.COV2.S
Jan 24, 2022
Compared with a homologous booster, a heterologous booster with an mRNA-based vaccine yielded a larger increase in binding antibodies.
Cancer patients with breakthrough COVID-19 remain at risk for severe outcomes
Dec 27, 2021
No significant difference was observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19.
Pfizer set to ask FDA to approve booster for those 18 and older
Nov 09, 2021
Peter Chin-Hong, M.D., an infectious-disease physician at the University of California, San Francisco, said there is “some value” in young people getting a booster to protect older relatives...
Allergic reactions to mRNA COVID-19 vaccines characterized
Sep 20, 2021
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria.
Dana Farber Cancer Center to retract or fix dozens of studies
Jan 23, 2024
(HealthDay News) — The prestigious Dana Farber Cancer Institute in Boston will retract six studies and correct 31 more as part of an ongoing investigation into claims of data manipulation. The action...
U.S. Surgeon General investigates COVID-19 misinformation
Mar 04, 2022
Murthy has requested input and data from tech companies, healthcare providers and community organizations.
